Analysis of:
Intravitreous Dexamethasone Drug Delivery System in Patients With Persistent Macular Edema (archopht.ama-assn.org)
A study reported in the March issue of Archives of Ophthalmology describes a new intravitreous drug delivery system for treating persistent retinal macular swelling. Using dexamethasone DDS and appropriate follow up, patients with this new system had significantly improved vision and and safety mea...
Analysis of:
Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage (www.retinajournal.com)
A study by Costa et al. reported in the prestigopis journal RETINA, of seven seven patients with macular SWELLING associated with ischemic retinal vein occlusion treated with intravitreal bevacizumab showed promising short-term results. Patients received two injections of bevacizumab (Avastin)...
Analysis of:
Artisan Phakic Intraocular Lens Safe, Effective After 10 Years (www.ophsource.org)
Tahzib et al. conducted a 10-year retrospective follow-up study of the Artisan phakic intraocular lens (PIOL) for the correction of moderate to high nearsigtedness and concluded the device is both stable and predictable, but only when strict inclusion criteria are used. Over 90% of patients achieved...
Analysis of:
Vegf Trap-Eye Phase 2 Wet Amd Results Reported At Arvo Annual Meeting (www.pipelinereview.com)
The VEGF Trap from Regeneron is a protein made up off human VEGF receptors fused to human immunoglobulin. This compound binds VEGF, preventing VEGF from binding to its natural receptors, interrupting the angiogenic cascade. The phase II study presented at 2007 ARVO showed promising results in patients...
Analysis of:
Ranibizumab, PDT combination successfully treats neovascular AMD (www.osnsupersite.com)
At the recent ARVO meeting, Italian researchers performing a randomized clinical trial on patients with wet AMD found that patients treated with photodynamic therapy (PDT) with Visudyne (verteporfin, Novartis) plus Lucentis(ranibizumab, Genentech) had a better visual result than patients treated with...
Analysis of:
Toric lens approval unlikely this year, STAAR Surgical says (www.ophthalmologytimes.com)
For a company that has had its share of rejections and problems with the approval of a phakic IOL (ICL Visian) that it tried to have enter the US market almost a decade ago, things are not improving much for Staar. The company recently reported that despite its request over one year ago...
Analysis of:
Better Vision Without Looking Your Age (www.nytimes.com)
Mutifocal iols are currently used to try to correct distance and near vision. While patients are often pleased by their improved near vision without glasses, many complain of poor optical quality for distance vision. Due to great out of pocket costs and poor quality of vision under some...
Analysis of:
Statins may reduce the risk of developing cataract, late AMD (www.osnsupersite.com)
Data mining is a career choice for a growing number of academic Ophthalmologists and Optometrists. Rightly so, since newer analyses of well conceived population data bases found in the Blue Mountain or the Framingham cohorts continue to provide valuable epidemiologic information.Burgeoning case loads...
Analysis of:
Femtosecond laser dominates discussion at ESCRS winter meeting (www.osnsupersite.com)
The ESCRS (European Society of Cataract & Refractive Surgery) actively engages Ophthalmologists who are seeking newer and better surgical procedures. This group self selects for innovative, aggressive, busy and entrepreneurial surgeons, as does its American counterpart, the ASCRS.Intralase technology...
Analysis of:
LASEK effectively treated post-LASIK myopic regression in study (www.osnsupersite.com)
The authors show less than stellar results following attempted enhancements of undercorrected or regressed myopic lasik. There are several alternatives to enhancement, including a repeat Lasik at a more shallow depth, lifting the previous Lasik flap and repeating the treatment, or a surface procedure.Surface...